243 related articles for article (PubMed ID: 23626689)
1. MTHFR Glu429Ala and ERCC5 His46His polymorphisms are associated with prognosis in colorectal cancer patients: analysis of two independent cohorts from Newfoundland.
Negandhi AA; Hyde A; Dicks E; Pollett W; Younghusband BH; Parfrey P; Green RC; Savas S
PLoS One; 2013; 8(4):e61469. PubMed ID: 23626689
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of MTHFR C677T and A1298C associated with survival in patients with colorectal cancer treated with 5-fluorouracil-based chemotherapy.
Yeh CC; Lai CY; Chang SN; Hsieh LL; Tang R; Sung FC; Lin YK
Int J Clin Oncol; 2017 Jun; 22(3):484-493. PubMed ID: 28044213
[TBL] [Abstract][Full Text] [Related]
3. Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer.
Gusella M; Frigo AC; Bolzonella C; Marinelli R; Barile C; Bononi A; Crepaldi G; Menon D; Stievano L; Toso S; Pasini F; Ferrazzi E; Padrini R
Br J Cancer; 2009 May; 100(10):1549-57. PubMed ID: 19384296
[TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients.
Etienne-Grimaldi MC; Milano G; Maindrault-Goebel F; Chibaudel B; Formento JL; Francoual M; Lledo G; André T; Mabro M; Mineur L; Flesch M; Carola E; de Gramont A
Br J Clin Pharmacol; 2010 Jan; 69(1):58-66. PubMed ID: 20078613
[TBL] [Abstract][Full Text] [Related]
5. Association between MTHFR polymorphisms and overall survival of colorectal cancer patients in Northeast China.
Zhu L; Wang F; Hu F; Wang Y; Li D; Dong X; Cui B; Zhao Y
Med Oncol; 2013 Mar; 30(1):467. PubMed ID: 23392576
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients.
Etienne MC; Formento JL; Chazal M; Francoual M; Magné N; Formento P; Bourgeon A; Seitz JF; Delpero JR; Letoublon C; Pezet D; Milano G
Pharmacogenetics; 2004 Dec; 14(12):785-92. PubMed ID: 15608557
[TBL] [Abstract][Full Text] [Related]
7. Association of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy.
Fernández-Peralta AM; Daimiel L; Nejda N; Iglesias D; Medina Arana V; González-Aguilera JJ
Int J Colorectal Dis; 2010 Feb; 25(2):141-51. PubMed ID: 19669769
[TBL] [Abstract][Full Text] [Related]
8. Combinations of polymorphisms in genes involved in the 5-Fluorouracil metabolism pathway are associated with gastrointestinal toxicity in chemotherapy-treated colorectal cancer patients.
Afzal S; Gusella M; Vainer B; Vogel UB; Andersen JT; Broedbaek K; Petersen M; Jimenez-Solem E; Bertolaso L; Barile C; Padrini R; Pasini F; Jensen SA; Poulsen HE
Clin Cancer Res; 2011 Jun; 17(11):3822-9. PubMed ID: 21471424
[TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?
Marcuello E; Altés A; Menoyo A; Rio ED; Baiget M
Cancer Chemother Pharmacol; 2006 Jun; 57(6):835-40. PubMed ID: 16187112
[TBL] [Abstract][Full Text] [Related]
10. Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene?
Suh KW; Kim JH; Kim DY; Kim YB; Lee C; Choi S
Ann Surg Oncol; 2006 Nov; 13(11):1379-85. PubMed ID: 17009149
[TBL] [Abstract][Full Text] [Related]
11. MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer.
Afzal S; Jensen SA; Vainer B; Vogel U; Matsen JP; Sørensen JB; Andersen PK; Poulsen HE
Ann Oncol; 2009 Oct; 20(10):1660-6. PubMed ID: 19465420
[TBL] [Abstract][Full Text] [Related]
12. Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer.
Chua W; Goldstein D; Lee CK; Dhillon H; Michael M; Mitchell P; Clarke SJ; Iacopetta B
Br J Cancer; 2009 Sep; 101(6):998-1004. PubMed ID: 19672255
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase polymorphisms and colorectal cancer prognosis: A meta-analysis.
Chen XL; Wang YM; Zhao F; Chen Z; Yang X; Sun C; Gao Y; Yang TG; Tian G; Chen YM; Zhu SL; Lin XB; Liu FB
J Gene Med; 2019 Sep; 21(9):e3114. PubMed ID: 31330573
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of folate metabolism-related genes and survival of patients with colorectal cancer in the Korean population.
Jang MJ; Kim JW; Jeon YJ; Chong SY; Hong SP; Hwang SG; Oh D; Cho YK; Ji YG; Kim NK
Gene; 2014 Jan; 533(2):558-64. PubMed ID: 24100087
[TBL] [Abstract][Full Text] [Related]
15. Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.
Hitre E; Budai B; Adleff V; Czeglédi F; Horváth Z; Gyergyay F; Lövey J; Kovács T; Orosz Z; Láng I; Kásler M; Kralovánszky J
Pharmacogenet Genomics; 2005 Oct; 15(10):723-30. PubMed ID: 16141798
[TBL] [Abstract][Full Text] [Related]
16. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
Sun K; Gong A; Liang P
Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
[TBL] [Abstract][Full Text] [Related]
17. Functional Analysis of SNPs in the ERCC5 Promoter in Advanced Colorectal Cancer Patients Treated With Oxaliplatin-Based Chemotherapy.
Chen J; Luo X; Xie G; Chen K; Jiang H; Pan F; Li J; Ruan Z; Pang X; Liang H
Medicine (Baltimore); 2016 May; 95(19):e3652. PubMed ID: 27175691
[TBL] [Abstract][Full Text] [Related]
18. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
Huang ZH; Hua D; Li LH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
[TBL] [Abstract][Full Text] [Related]
19. The association of polymorphisms in folate-metabolizing genes with response to adjuvant chemotherapy of colorectal cancer.
Yousef AM; Zawiah M; Al-Yacoub S; Kadi T; Tantawi DA; Al-Ramadhani H
Cancer Chemother Pharmacol; 2018 Aug; 82(2):237-243. PubMed ID: 29845393
[TBL] [Abstract][Full Text] [Related]
20. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients.
Sharma R; Hoskins JM; Rivory LP; Zucknick M; London R; Liddle C; Clarke SJ
Clin Cancer Res; 2008 Feb; 14(3):817-25. PubMed ID: 18245544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]